Has Evolent Health (EVH) Outpaced Other Computer and Technology Stocks This Year?

EVH

Investors focused on the Computer and Technology space have likely heard of Evolent Health (EVH - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer this question is to take a look at the year-to-date performance of EVH and the rest of the Computer and Technology group's stocks.

Evolent Health is a member of the Computer and Technology sector. This group includes 628 individual stocks and currently holds a Zacks Sector Rank of #5. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. EVH is currently sporting a Zacks Rank of #2 (Buy).

Over the past 90 days, the Zacks Consensus Estimate for EVH's full-year earnings has moved 3.83% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.

Based on the most recent data, EVH has returned 84.55% so far this year. At the same time, Computer and Technology stocks have gained an average of 8%. This means that Evolent Health is performing better than its sector in terms of year-to-date returns.

Looking more specifically, EVH belongs to the Internet - Software industry, which includes 70 individual stocks and currently sits at #92 in the Zacks Industry Rank. On average, stocks in this group have gained 22.21% this year, meaning that EVH is performing better in terms of year-to-date returns.

Investors with an interest in Computer and Technology stocks should continue to track EVH. The stock will be looking to continue its solid performance.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>